Login to Your Account

NCI Grant Gives Almost $18M To Advance Myeloma Research

By Randall Osborne

Thursday, August 26, 2004
Industry has made significant inroads over the years against multiple myeloma - Millennium Pharmaceuticals Inc.'s Velcade, approved in May 2003, comes to mind - but academia also has chalked up important gains against the rare, deadly blood cancer. (BioWorld Today)

To continue reading subscribe now to BioWorld Today

Learn More about BioWorld Today

Already a subscriber? Sign In or Buy now to activate your subscription